Long lasting smooth muscle relaxation by a novel PACAP analogue in guinea-pig and primate airways in vitro

British Journal of Pharmacology

Volumn 121, Issue 8, 1997, Pages 1730-1734

  Yoshihara, Shigemi ^a,b   Lindén, Anders ^a   Kashimoto, Kazuhisa ^c   Nagano, Yumiko ^c   Ichimura, Tohju ^b   Nadel, Jay A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c Itoham Central Research Institute   (Japan)

Author keywords

Bronchodilator; Guinea pig airways; Pituitary adenylate cyclase activating peptide (PACAP); Primate airways; Salbutamol; Smooth muscle relaxation

Indexed keywords

BRONCHODILATING AGENT; CAPTOPRIL; CARBACHOL; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; PACAP DERIVATIVE; PEPTIDASE; PHOSPHORAMIDON; SALBUTAMOL; UNCLASSIFIED DRUG;

AIRWAY; ANIMAL TISSUE; ARTICLE; BRONCHUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; ENZYME INHIBITION; GUINEA PIG; MALE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION; TRACHEA;

ALBUTEROL; ANIMALS; BRONCHI; CAPTOPRIL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOPEPTIDES; GUINEA PIGS; MACACA FASCICULARIS; MALE; MUSCLE RELAXATION; NEUROPEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; TRACHEA;

EID: 0030837834     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701310     Document Type: Article

References (14)

1. ARAKI, N. & TAKAGHI, K. (1992). Relaxant effect of pituitary adenylate cyclase-activating polypeptide on guinea pig tracheal smooth muscle. Eur. J. Pharmacol., 216, 113-117.
2. ARIMURA, A. (1992). Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research. Reg. Peptides, 37, 287-303.
3. BARNES, P. & DIXON, C.M. (1984). The effect of inhaled vasoactive intestinal polypeptide on bronchial reactivity to histamine in humans. Am. Rev. Respir. Dis., 130, 162-166.
4. BHOGAL, R., SHELDRlCK, R.L.G., COLEMAN, R.A., SMITH, D.M. & BLOOM, S.R. (1994). The effects of PACAP and VIP on guinea pig tracheal smooth muscle in vitro. Peptides, 15, 1237-1241.
5. CARDELL, L-O., UDDMAN, R., LUTS, A. & SUNDLER, F. (1991). Pituitary adenylate-cyclase activating peptide (PACAP) in guinea pig lung: distribution and dilatory effects. Reg. Peptides, 26, 379-390.
6. ISHIZUKA, Y., KASHIMOTO, K., MOCHIZUKI, T., SATO, K., OHSHIMA, K. & YANAIHARA, N. (1992). Cardiovascular and respiratory actions of pituitary adenylate cyclase-activating polypeptides. Reg. Peptides, 40, 29-39.
7. +-ATPase in airway smooth muscle relaxation by vasoactive intestinal peptide and pituitary adenylate cyclase activating peptide. Res. Commun. Chem. Pathol. Pharmacol., 79, 11-22.
8. KASHIMOTO, K., NAGANO, Y., SUITANI, Y., HAMANAKA, K., MIZUMOTO, T., TOMIZAKI, K., TAKAHATA, H., NAGAMOTO, A., OHATA, A., YOSHIHARA, S. & ICHIMURA, T. (1996). Structure-activity relationship studies of PACAP 27 and VIP analogue. 2nd International symposium on VIP, PACAP and Related Peptides. Ann. New York Acad. Sci. (in press).
9. LINDÉN, A., BERGENDAL, A., ULLMAN, A., SKOOGH, B-E. & LÖFDAHL, C-G. (1993). Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism. Thorax, 48, 547-553.
10. LINDEN, A., YOSHIHARA, S., CHAN, B. & NADEL, J.A. (1995). Inhibition of bronchoconstriction by pituitary adenylate-cyclase activating peptide (PACAP 1-27) in guinea-pigs in vivo. Br. J. Pharmacol., 115, 913-916.
11. LUTS, A., UDDMAN, R., ALM, P., BASTERRA, J. & SUNDLER, F. (1993). Peptide-containing nerve fibres in human airways: distribution and coexistence pattern. Int. Arch. Allergy Immunol., 101, 52-60.
12. MORICE, A., UNWIN, R.J. & SEVER, P.S. (1983). Vasoactive intestinal peptide causes bronchodilation and protects against histamine-induced bronchoconstriction in asthmatic subjects. Lancet, 2, 1225-1226.
13. NANDHA, K.A., BENITO-ORFILA, M.A., SMITH, D.M., GHATEI, M.A. & BLOOM, S.R. (1991). Action of pituitary adenylate-cyclase-activating polypeptide and vasoactive intestinal polypeptide on the rat vascular system: effects on blood pressure and receptor binding. J. Endocrinol., 129, 69-73.
14. O'DONNELL, M., GARIPPA, R.J., RINALDI, N., SELIG, W.M., TOCKER, J.E., TANNU, S.A., WASSERMAN, M.A., WELTON, A. & BOLIN, D.R. (1994). Ro-25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part II: Effect on in vitro and in vivo models of pulmonary anaphylaxis. J. Pharmacol. Exp. Ther., 210, 1289-1294.